Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) saw a large increase in short interest in September. As of September 15th, there was short interest totaling 140,300 shares, an increase of 217.4% from the August 31st total of 44,200 shares. Based on an average trading volume of 296,800 shares, the days-to-cover ratio is currently 0.5 days. Based on an average trading volume of 296,800 shares, the days-to-cover ratio is currently 0.5 days.
Terumo Trading Up 1.0%
OTCMKTS:TRUMY opened at $16.52 on Thursday. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.64 and a quick ratio of 1.53. Terumo has a 12-month low of $15.64 and a 12-month high of $21.22. The business has a 50 day simple moving average of $17.62 and a 200 day simple moving average of $18.08. The firm has a market capitalization of $24.46 billion, a P/E ratio of 28.98 and a beta of 0.79.
Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.80 billion. Terumo had a return on equity of 9.19% and a net margin of 12.09%.
About Terumo
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.